SunWay Biotech Co., LTD. (1271.TWO) stock: key figures, P/E, revenue and dividend
Consumer Staples · Taiwan · ISIN TW0001271005
SunWay Biotech Co., LTD. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 970.18 m TWD | 993.30 m TWD |
| Gross profit | 545.04 m TWD | 560.50 m TWD |
| Operating income | 140.98 m TWD | 104.13 m TWD |
| EBIT | 147.67 m TWD | 126.69 m TWD |
| Net income | 118.57 m TWD | 101.50 m TWD |
| Diluted EPS – continuing operations | 1.96 TWD | 1.69 TWD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SunWay Biotech Co., LTD.
SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company offers red yeast rice and lactic acid bacteria products, as well as other health supplements; and wholesale and manufacturing of pharmaceutical products. The company also researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan.
More stocks
- TMT Steel Public Company Limited (TMT.BK)
- TC Materials Co.,Ltd. (125020.KQ)
- Meridia Real Estate III Socimi SA (YMRE.MC)
- KHD Humboldt Wedag International (KWG.DE)
- NAUROBOTICS (459510.KQ)
- SMITH MIDLAND CORP (SMID)
- Corpovael S.A.B. de C.V (CADUA.MX)
- Otsuka Information Technology Corp. (3570.TWO)
- Phoenix Tours International Inc (5706.TW)
- Wellspire Holdings Berhad (0271.KL)
- Daesung Ind (128820.KS)
- Currenc Group Inc. (CURR)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.